Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Carcinoma, Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03755115
What this trial is testing

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06497530
What this trial is testing

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 30
Testing effectiveness (Phase 2)Study completedNCT00006082
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 38
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)WithdrawnNCT05572476
What this trial is testing

Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung CancerPlatinum-Sensitive Lung Small Cell CarcinomaExtensive-stage Small-cell Lung Cancer
Institut Bergonié
Early research (Phase 1)Study completedNCT03898791
What this trial is testing

LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 48
Early research (Phase 1)Study completedNCT05002868
What this trial is testing

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Who this might be right for
Solid TumorExtensive-stage Small-cell Lung CancerLocally Advanced Breast Cancer+4 more
Rhizen Pharmaceuticals SA 23
Not applicableApproved For MarketingNCT06064500
What this trial is testing

Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Amgen
Early research (Phase 1)Study completedNCT00249964
What this trial is testing

Combination Paclitaxel, Carboplatin and Temozolomide

Who this might be right for
Lung DiseasesCancer
New Mexico Cancer Research Alliance 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT06951841
What this trial is testing

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Who this might be right for
Small Cell Lung Cancer
China Medical University, China 31
Testing effectiveness (Phase 2)Ended earlyNCT04373369
What this trial is testing

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 11
Not applicableNot Yet RecruitingNCT06462105
What this trial is testing

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Zhou Chengzhi 60
Testing effectiveness (Phase 2)Looking for participantsNCT07480213
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCSCLC, Extensive Stage
Beijing Biotech 60
Testing effectiveness (Phase 2)Looking for participantsNCT06698965
What this trial is testing

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

Who this might be right for
Lung Cancer, Small Cell
Shanghai Chest Hospital 52
Large-scale testing (Phase 3)Not Yet RecruitingNCT07796100
What this trial is testing

ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 530
Testing effectiveness (Phase 2)WithdrawnNCT00472771
What this trial is testing

INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
CytRx
Not applicableStudy completedNCT04894591
What this trial is testing

To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jazz Pharmaceuticals 272
Testing effectiveness (Phase 2)Looking for participantsNCT06536868
What this trial is testing

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Second Hospital of Shanxi Medical University 40
Testing effectiveness (Phase 2)UnknownNCT04675697
What this trial is testing

Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Xiangya Hospital of Central South University 36
Large-scale testing (Phase 3)Study completedNCT00003917
What this trial is testing

Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 4
Next Page